feed,title,long_url,short_url
SeekingAlpha,CrowdStrike raises full-year guidance for second time this year,https://seekingalpha.com/news/3735847,
SeekingAlpha,Teva's subcutaneous risperidone NDA for schizophrenia accepted by FDA,https://seekingalpha.com/news/3735845,
SeekingAlpha,IF Bancorp reports FQ4 results,https://seekingalpha.com/news/3735844,
